{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:08:03Z","timestamp":1767791283067,"version":"3.49.0"},"reference-count":27,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["516022531"],"award-info":[{"award-number":["516022531"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Health Care Inform"],"accepted":{"date-parts":[[2025,4,17]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>There is a bidirectional interaction between clinical practice guidelines and clinical care, with each informing the other. Structural signalling of trends in guideline adherence in clinical practice is essential for advanced updates. Recent advances in computable care guidelines allow automated evaluation using real-world registry data. Here, we assess the feasibility by evaluating adherence to Dutch endometrial cancer (EC) guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study uses real-world data of EC patients from the Netherlands Cancer Registry (NCR) between January 2010 and May 2022. The Dutch guideline for EC was parsed into clinical decision trees (CDTs). Primary outcome was guideline adherence for multiple (sub)populations, with secondary outcomes encompassing adherence trends, recommendation implementation pace, non-adherent treatment strategies and impact of additional non-guideline-based patient and tumour characteristics on adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Dutch EC guideline was parsed into 10 CDTs, revealing 22 patient and disease characteristics and 46 interventions. NCR data were mapped to CDT data items. Four CDTs were successfully populated with NCR data, and 21\u2009602 cases were assessed. Adherence levels were computed, which showed a mean adherence of 82.7% (range 44\u2013100%). Three statistically significant trends in adherence were identified: two increasing trends in the \u2018non-adherent\u2019 compared with the \u2018adherent\u2019 group, and one decreasing trend.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study introduces a novel framework for continuously evaluating (non-)adherence to cancer guidelines. Future efforts should focus on the inclusion of health outcome measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Through the integration of real-world data with a computer-interpretable guideline, we effectively calculated various facets of adherence to guidelines for EC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjhci-2024-101333","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:44:20Z","timestamp":1747313060000},"page":"e101333","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging real-world data for continuous evaluation of computational clinical practice guidelines"],"prefix":"10.1136","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1069-2357","authenticated-orcid":false,"given":"Kees C W J","family":"Ebben","sequence":"first","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands"},{"name":"Department of Epidemiology, GROW-school for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis D","family":"de Kroon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Channa E","family":"Schmeink","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Anna Hospital, Geldrop, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga L","family":"van der Hel","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs","family":"van Vegchel","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Thissen","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace H J T","family":"de Hingh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, GROW-school for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Surgical Oncology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurrian","family":"van der Werf","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2026010700452172000_32.1.e101333.1","doi-asserted-by":"crossref","unstructured":"Graham R , Mancher M , Miller D , et al . Clinical practice guidelines we can trust; Institute of medicine. Washington (DC): National Academies Press (US), 2011:300","DOI":"10.17226\/13058"},{"key":"2026010700452172000_32.1.e101333.2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-9-3"},{"key":"2026010700452172000_32.1.e101333.3","unstructured":"IKNL . ALERTNESS project page. 2021. Available: https:\/\/iknl.nl\/en\/guidelines\/alertness;-structural-signaling-for-up-to-date-gui"},{"key":"2026010700452172000_32.1.e101333.4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2026010700452172000_32.1.e101333.5","unstructured":"Organization NCC . NKR cijfers. 2023. Available: https:\/\/nkr-cijfers.iknl.nl\/#\/viewer\/2370c08a-9332-4c8a-9d8c-a3af468ffb5a"},{"key":"2026010700452172000_32.1.e101333.6","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-015-0369-z","article-title":"Reporting standards for guideline-based performance measures","volume":"11","author":"Nothacker","year":"2016","journal-title":"Implement Sci"},{"key":"2026010700452172000_32.1.e101333.7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00404-021-06140-5","article-title":"Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study","volume":"305","author":"Scharl","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"2026010700452172000_32.1.e101333.8","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1007\/s00432-022-04318-1","article-title":"Guideline concordant therapy improves survival in high-grade endometrial cancer patients","volume":"149","author":"Scharl","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026010700452172000_32.1.e101333.9","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/cncr.33502","article-title":"Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas","volume":"127","author":"Rodriguez","year":"2021","journal-title":"Cancer"},{"key":"2026010700452172000_32.1.e101333.10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000004424","article-title":"Racial-Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Endometrial Cancer","volume":"138","author":"Rodriguez","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2026010700452172000_32.1.e101333.11","first-page":"2977","article-title":"Adherence to Guidelines During Follow-up of Endometrial Cancer: Analysis of French Health Insurance Database","volume":"38","author":"Phelippeau","year":"2018","journal-title":"Anticancer Res"},{"key":"2026010700452172000_32.1.e101333.12","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e76","article-title":"Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee","volume":"28","author":"Shigeta","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"2026010700452172000_32.1.e101333.13","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000284"},{"key":"2026010700452172000_32.1.e101333.14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.32740","article-title":"Guideline-concordant endometrial cancer treatment and survival in the Women\u2019s Health Initiative Life and Longevity After Cancer study","volume":"147","author":"Felix","year":"2020","journal-title":"Int J Cancer"},{"key":"2026010700452172000_32.1.e101333.15","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.464"},{"key":"2026010700452172000_32.1.e101333.16","unstructured":"IKNL . NKR itemset endometrial cancer (in Dutch). 2023. Available: https:\/\/iknl.nl\/getmedia\/c40a4a44-1b53-4b05-b028-923d84be0d27\/nkr_itemset_gynaecologie_endometrium.pdf"},{"key":"2026010700452172000_32.1.e101333.17","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S2589-7500(21)00038-8","article-title":"WHO SMART guidelines: optimising country-level use of guideline recommendations in the digital age","volume":"3","author":"Mehl","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026010700452172000_32.1.e101333.18","doi-asserted-by":"crossref","DOI":"10.1002\/lrh2.10384","article-title":"A novel method for continuous measurements of clinical practice guideline adherence","volume":"7","author":"Ebben","year":"2023","journal-title":"Learn Health Syst"},{"key":"2026010700452172000_32.1.e101333.19","doi-asserted-by":"crossref","DOI":"10.1200\/CCI.23.00045","article-title":"Opportunities and Challenges of Synthetic Data Generation in Oncology","volume":"7","author":"Jacobs","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"2026010700452172000_32.1.e101333.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00150","article-title":"Transformation of the National Breast Cancer Guideline Into Data-Driven Clinical Decision Trees","volume":"3","author":"Hendriks","year":"2019","journal-title":"JCO Clinical Cancer Informatics"},{"key":"2026010700452172000_32.1.e101333.21","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/jamia\/ocab084","article-title":"The use of SNOMED CT, 2013-2020: a literature review","volume":"28","author":"Chang","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"2026010700452172000_32.1.e101333.22","unstructured":"CRGO GCfGO . Guideline based clinical decision trees for endometrial cancer. 2022. Available: https:\/\/oncoguide.nl\/#!\/projects\/81\/guideline"},{"key":"2026010700452172000_32.1.e101333.23","first-page":"616","article-title":"Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics","volume":"27","author":"Heins","year":"2017","journal-title":"Eur J Public Health"},{"key":"2026010700452172000_32.1.e101333.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.02.008"},{"key":"2026010700452172000_32.1.e101333.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076175","article-title":"Data to knowledge to improvement: creating the learning health system","volume":"384","author":"McDonald","year":"2024","journal-title":"BMJ"},{"key":"2026010700452172000_32.1.e101333.26","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"2026010700452172000_32.1.e101333.27","doi-asserted-by":"publisher","DOI":"10.1111\/his.14015"}],"container-title":["BMJ Health &amp; Care Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjhci-2024-101333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:45:35Z","timestamp":1767775535000},"score":1,"resource":{"primary":{"URL":"https:\/\/informatics.bmj.com\/lookup\/doi\/10.1136\/bmjhci-2024-101333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,12]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjhci-2024-101333"],"URL":"https:\/\/doi.org\/10.1136\/bmjhci-2024-101333","relation":{},"ISSN":["2632-1009"],"issn-type":[{"value":"2632-1009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}